Monthly Archives: June 2006

Pregnant 18 Year Old Dies After Hospital Error

There is nothing as tragic as a young life lost- especially when that lost life is not a result of circumstances beyond control. Elisha Crews Bryant, 18, went to South Florida Baptist Hospital because she was experiencing premature labor pains. A nurse gave her 4 times the amount of magnesium sulfate, a common treatment to retard early labor. The baby survived but will live life without a mother.

Fosamax and Jaw Death

There was an interesting article published this morning in the NY Timesregarding osteoporosis drugs and osteonecrosis. According to the article, two groups of people take the osteoporosis drugs which belong to the bisphosphonate family. The first group, those suffering from breast cancer and/or multiple myeloma whose disease has spread to the bone, receive the drug intravenously. The second class of bisphosphonate users are those suffering from osteoporosis. Normally, these folks take a drug like Fosamax orally. If you have questions or concerns about the risk factors associated with Fosamax or other bisphosphonates, consult your physician.

Monsignor Fushek Trial on Hold for Now

Monsignor Dale Fushek, founder of Life Teen and the former No. 2 man in the Diocese of Phoenix, has had his sex trial put on hold until an appeal is heard. The appeal centers around Fushek’s request for a jury trial rather than a trial in front of a magistrate. The defense has contended that the allegations are spurious because they involve the counsel Fushek gave boys regarding sexual sins.

Continue reading

Large Corporations Pressure EPA to Approve Dangerous Pesticides

Agricultural and chemical companies are lobbying the EPA to approve license extensions for approximately 20 pesticides that are suspected to retard brain growth in unborn babies and children. The pesticides include Orthene, Trithion, Nemacur and Dursban, are generally sold for use on farms rather than in homes. In spite of its function as a regulatory agency, the EPA has been criticized for its regulatory handling of dangerous pesticides, according to environmental watchdog groups.

Good Science and Merck

Merck acknowledged Tuesday that a statistical analysis test used to reach the conclusion, published in a March 2005 New England Journal of Medicine article, did not support its theory of potential heart problems only after 18 months of continuous Vioxx use. The test actually showed there was 7 percent chance that Vioxx posed an equally high heart attack risk before and after the 18-month window, the Times reported.